Back to News
Market Impact: 0.3
Scancell Secures Up To $25 Mln Debt Facility To Fund ISCIB1+ Phase 3
Source: Nasdaq
Healthcare & BiotechCredit & Bond MarketsCompany Fundamentals
Scancell Holdings entered a loan agreement with BlackRock-managed funds and accounts for a debt facility of up to $25 million. The financing provides the biotech company with additional capital and liquidity, though the article does not disclose drawdown terms, pricing, or intended use of proceeds.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
BLK0.15
SCLP0.55
More News
- Jensen Huang’s $21 billion net worth in AI rout—Nvidia’s recovery will be ‘capped’ after he admitted affair with alleged Chinese spy
- Nvidia's CEO turmoil gives newly empowered Democrats fresh ammunition in pursuit of oversight
- Paraguay raids ex-president’s home: Why a bank crash brought down Pena
- Banks, investors grow wary of AI debt, spooked by market selloff
- Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
- Musk says Tesla will refund some Cybertruck deposits, defends decision to end production